Inside the research
U.S. Physical Therapy, Inc.
USPH Research profile · latest available data
Price overview
$84.84
▲ +1.08 (+1.3%)
| 52w hi | $90.82 |
|---|---|
| 52w lo | $58.22 |
| Vol | 124.10K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.09
| Short | +0.19 |
|---|---|
| Medium | +0.17 |
| Long | -0.28 |
computed 2026-09-27
Key fundamentals
U.S. Physical Therapy, Inc.
Healthcare · Medical Care Facilities
| Market cap | $1.27B |
|---|---|
| Enterprise value | $1.94B |
| Trailing P/E | 471.33x |
| Forward P/E | 25.33x |
| EV / EBITDA | 19.05x |
| P / S (ttm) | 1.57x |
| Profit margin | 4.0% |
| Return on equity | 6.5% |
| Revenue growth | +8.5% |
| Earnings growth | -56.5% |
| Debt / equity | 50.32 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.00 | |
| Sector | +0.08 | |
| Technical | +0.12 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Risk Metrics
| Beta vs SPX | 0.82 |
|---|---|
| Corr SPX | 0.36 |
| Annual vol | 37.2% |
| Annual ret | +7.9% |
| Sharpe | 0.21 |
| Max DD | -40.9% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-14 | Material Agreement, Officer / Director Change… | read |
| 2026-08-12 | Reg FD Disclosure, Exhibits | read |
| 2026-08-10 | Reg FD Disclosure, Exhibits | read |
| 2026-08-06 | Earnings Release, Other Material Event… | read |
| 2026-07-06 | Other Material Event, Exhibits | read |
| 2026-05-19 | Shareholder Vote | read |
| 2026-05-11 | Reg FD Disclosure, Exhibits | read |
| 2026-05-06 | Earnings Release, Other Material Event… | read |
| 2026-04-15 | Material Agreement, Material Obligation… | read |
| 2026-03-13 | Officer / Director Change, Exhibits | read |
| 2026-03-09 | Reg FD Disclosure, Exhibits | read |
| 2026-03-03 | Reg FD Disclosure, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 95.1% |
| HHI | 4,103 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $48.58M | 707.19K |
| Fidelity / FMR LLC | $9.84M | 143.23K |
| Citadel Advisors | $6.27M | 91.35K |
| Capital Research / Capital World | $5.53M | 80.57K |
| Renaissance Technologies | $4.88M | 71.00K |
| Millennium Management | $2.50M | 36.42K |
| AQR Capital Management | $1.36M | 19.84K |
| T. Rowe Price Group | $1.71K | 24.93K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $671.35M | +8.6% | |
| Gross profit | $121.51M | +5.2% | |
| Operating income | $86.68M | +6.5% | |
| Net income | $31.42M | +2.9% | |
| Cash from ops | $81.98M | +7.3% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $83.76 | $85.31 | $83.76 | $84.84 | 124.10K |
| Sep 24 | $82.68 | $84.88 | $82.68 | $83.76 | 175.70K |
| Sep 23 | $83.24 | $83.96 | $81.86 | $82.65 | 131.20K |
| Sep 22 | $83.27 | $85.26 | $82.42 | $83.17 | 217.00K |
| Sep 21 | $82.23 | $83.35 | $81.90 | $82.45 | 169.80K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →